Eubiologics Co. Ltd. researches and develops biopharmaceuticals. The Company offers bacterial vaccines for new epidemics and antibiotic resistance. Eubiologics operates in South Korea.

Interim Report on Business Performance(Fair Disclosure)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Eubiologics (206650 KS)

Interim Report on Business Performance(Fair Disclosure)

Material Management Information related to Judgment of Investment(???-??????(???) ??? ?? ???? ??)

Material Management Information related to Judgment of Investment(ì í°í-ì¨ì£¼ë©í°ëì¦(ìì¶ì©) ë°±ì ì íêµ íëª©íê° ì ì²)

Contract for Sales or Supply (Voluntary Disclosure)

Contract for Sales or Supply (Voluntary Disclosure)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Interim Report on Business Performance(Fair Disclosure)

Material Management Information related to Judgment of Investment(???-??????(???) ??? ?? ???? ??)

Material Management Information related to Judgment of Investment(ì í°í-ì¨ì£¼ë©í°ëì¦(ìì¶ì©) ë°±ì ì íêµ­ íëª©íê° ì ì²­)

Contract for Sales or Supply (Voluntary Disclosure)

Contract for Sales or Supply (Voluntary Disclosure)

Material Management Information related to Judgment of Investment(ì í°í-ì¨ì£¼ë©í°ëì¦(ìì¶ì©) ë°±ì ì íêµ íëª©íê° ì ì²)